Ballentine Partners »

Vir Biotechnology shares owned by Ballentine Partners

Quarter-by-quarter ownership of Vir Biotechnology (VIR) shares owned by Ballentine Partners from 13F filings

Historical chart of Ballentine Partners investment in Vir Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Vir Biotechnology held by Ballentine Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vir Biotechnology by Ballentine Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $139k 14k 10.13
2023-12-31 $126k 13k 10.06
2023-09-30 $100k 11k 9.37

More positions owned by Ballentine Partners

Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Core Msci Emkt (IEMG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Real Estate Etf (VNQ)
Vanguard Index Fds Large Cap Etf (VV)
Microsoft Corporation (MSFT)
Ishares Tr Rus 1000 Etf (IWB)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Apple (AAPL)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Ballentine Partners

Top funds holding Vir Biotechnology

Vanguard Group
Baillie Gifford & Co
Citadel Advisors
Alliancebernstein
Bill & Melinda Gates Foundation
Bank of New York Mellon
D. E. Shaw & Co
Charles Schwab Investment Management
Goldman Sachs Group
Voloridge Investment Management
UBS Group
Dimensional Fund Advisors
Principal Financial Group
Barclays
Millennium Management

View all funds holding Vir Biotechnology